IGPH — IGEA Pharma NV Balance Sheet
0.000.00%
- CH₣0.51m
- CH₣0.90m
Annual balance sheet for IGEA Pharma NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.88 | 0.398 | 0.11 | 0.017 | 0.03 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.68 | 0.099 | 0.108 | 0.196 | 0.056 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.56 | 0.509 | 0.237 | 1.13 | 0.222 |
| Net Property, Plant And Equipment | 0.09 | 0.076 | 0.02 | — | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 3.04 | 0.952 | 0.599 | 11.4 | 0.222 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.816 | 0.467 | 0.428 | 1.55 | 1.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.796 | 0.446 | 0.421 | 2.13 | 2.52 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.24 | 0.506 | 0.178 | 9.32 | -2.3 |
| Total Liabilities & Shareholders' Equity | 3.04 | 0.952 | 0.599 | 11.4 | 0.222 |
| Total Common Shares Outstanding |